Paromomycin

Paromomycin

SCHEMBL1680052

NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O.O=S(=O)(O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Paromomycin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 1.00
RECQL P46063 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
HSD17B10 Q99714 1/20 0.89
TSHR P16473 1/20 0.89
MEN1 O00255 1/20 0.87
LRAT O95237 1/20 0.87
TRPV1 Q8NER1 1/20 0.87
LMNA P02545 1/20 0.81
MAPT P10636 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Paromomycin SCHEMBL691558 1.00 BLM (1.00) BLMRECQLTDP1HSD17B10TSHR
Paromomycin SCHEMBL2527138 1.00 BLM (1.00) BLMRECQLTDP1HSD17B10TSHR
Paromomycin SCHEMBL3355 1.00 BLM (1.00) BLMRECQLTDP1HSD17B10TSHR
Framycetin SCHEMBL3696748 0.99 BLM (0.98) BLMRECQLTDP1HSD17B10TSHR
Framycetin SCHEMBL2133931 0.99 BLM (0.98) BLMRECQLTDP1HSD17B10TSHR
Framycetin SCHEMBL29628935 0.99 BLM (0.98) BLMRECQLTDP1HSD17B10TSHR
Framycetin SCHEMBL285111 0.99 BLM (0.98) BLMRECQLTDP1HSD17B10TSHR
Framycetin SCHEMBL373681 0.99 BLM (0.98) BLMRECQLTDP1HSD17B10TSHR
Framycetin SCHEMBL2133938 0.99 BLM (0.98) BLMRECQLTDP1HSD17B10TSHR
Paromomycin SCHEMBL28264135 0.97 BLM (0.94) BLMRECQLTDP1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4746516-A STORAGE STABILITY, PURITY FARMITALIA CARLO ERBA S.P.A. (IT) 1988-05-24 US claimed
EP-2663335-A1 A COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES Medestea Internazionale S.p.A. (IT) 2013-11-20 EP disclosed
WO-2012095702-A1 A COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES MEDESTEA INTERNAZIONALE S.P.A. (IT) 2012-07-19 WO disclosed
WO-2011050192-A1 MODULATION OF AXON DEGENERATION GENENTECH, INC. (US) 2011-04-28 WO disclosed
EP-2227083-A1 COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES Medevice S.P.A. (IT) 2010-09-15 EP disclosed
WO-2009069022-A1 COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES MEDEVICE S.P.A. (IT) 2009-06-04 WO disclosed
EP-0412982-A1 PAROMOMYCIN OR DERIVATIVES THEREOF FOR PARENTERAL TREATMENT OF HUMAN PARASITIC DISEASES. ERBA CARLO SPA (IT) 1991-02-20 EP disclosed
US-4746516-A STORAGE STABILITY, PURITY FARMITALIA CARLO ERBA S.P.A. (IT) 1988-05-24 US disclosed
US-4746516-A STORAGE STABILITY, PURITY FARMITALIA CARLO ERBA S.P.A. (IT) 1988-05-24 US disclosed
US-4460577-A Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same FARMITALIA CARLO ERBA S.P.A. (IT) 1984-07-17 US disclosed
US-4460577-A Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same FARMITALIA CARLO ERBA S.P.A. (IT) 1984-07-17 US disclosed